| Yohimbine | IC50 | 8.0 [1], 95.0 [2] |
| Yohimbine | Ki | 3.8 [1] |
| Oxymetazoline | Ki | 14.0 [1] |
| Prazosin | Ki | 540.0 [1] |
| Rauwolscine | Ki | 1.2 [1] |
| Clonidine | IC50 | 21.0 [1] |
| Clonidine | Ki | 3.8 [1], 20.89 [2] |
| Corynanthine | IC50 | 211000.0 [1], 340000.0 [2], 871000.0 [3], 1038000.0 [4] |
| Brimonidine | IC50 | 3.0 [1] |
| Brimonidine | Ki | 1.41 [1], 2.4 [2] |
| Olanzapine | Ki | 140.0 [1], 230.0 [2], 263.0 [3] |
| 2-Methoxyidazoxan | Ki | 0.91 [1], 1.41 [2] |
| Epinephrine | IC50 | 8.0 [1] |
| Epinephrine | Ki | 5.0 [1] |
| Clozapine | Ki | 51.0 [1], 160.0 [2] |
| Risperidone | Ki | 1.8 [1], 7.5 [2] |
| Quetiapine | Ki | 87.0 [1], 1100.0 [2] |
| Ziprasidone | Ki | 390.0 [1] |
| Cisapride | IC50 | 4500.0 [1] |
| Idazoxan | Ki | 51.29 [1] |
| Medetomidine | IC50 | 2900.0 [1], 3300.0 [2] |
| Zotepine | Ki | 180.0 [1], 960.0 [2] |
| 1,2,3,4-Tetrahydroisoquinoline-7-sulfonamide | Ki | 100000.0 [1] |
| 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | IC50 | 10000.0 [1] |
| 4-Amino-5-chloro-N-((hexahydro-1H-pyrrolizin-1-yl)methyl)-2-methoxybenzamide hydrochloride | Ki | 10000.0 [1] |
| 4-(1-Naphthalen-1-yl-ethyl)-1H-imidazole | IC50 | 0.0 [1], 4300.0 [2] |
| 4-Amino-N-[(4R)-1-azatricyclo[3.3.1.03,7]nonan-4-yl]-5-chloro-2-methoxybenzamide | IC50 | 10000.0 [1] |
| N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methylquinoxalin-6-amine | Ki | 1.3 [1] |
| N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-1,2,3,4-tetrahydroquinoxalin-6-amine | Ki | 6.8 [1], 9.6 [2] |
| N-(4,5-Dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | Ki | 41.0 [1], 64.0 [2] |
| 5-O-[2-[[(3S)-2,3-Dihydro-1,4-benzodioxin-3-yl]methyl-methylamino]ethyl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | IC50 | 1000.0 [1], 100000.0 [2] |
| Norepinephrine | Ki | 30.0 [1] |
| Phenylephrine | Ki | 390.0 [1] |
| Haloperidol | Ki | 5000.0 [1] |
| Phentolamine | Ki | 5.0 [1] |
| Nicardipine | IC50 | 10000.0 [1] |
| Zafirlukast | IC50 | 10000.0 [1] |
| Moxonidine | Ki | 75.0 [1] |
| Apraclonidine | IC50 | 4.0 [1] |
| Sertindole | Ki | 1680.0 [1] |
| Rilmenidine | Ki | 180.0 [1] |
| Ipsapirone | IC50 | 1000.0 [1] |
| Naphazoline hydrochloride | IC50 | 0.0 [1] |
| Xylometazoline | Ki | 500.0 [1] |
| Efaroxan | Ki | 51.29 [1] |
| GR-127935 | Ki | 1000.0 [1] |
| Vilazodone | IC50 | 6000.0 [1] |
| 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | Ki | 21.0 [1] |
| Benalfocin | Ki | 16.7 [1] |
| 6-Fluoronorepinephrine | Ki | 12.0 [1] |
| 1-(1-Methylindol-5-yl)-3-(3-methyl-1,2-thiazol-5-yl)urea | Ki | 1000.0 [1] |
| p-Iodoclonidine | IC50 | 1.5 [1] |
| N-Desmethylolanzapine | Ki | 1000.0 [1] |
| 4-(2-Amino-1-hydroxyethyl)-3-fluorobenzene-1,2-diol | Ki | 700.0 [1] |
| [2-(5-Chloro-2-methyl-1H-indol-3-yl)-ethyl]-dimethyl-amine | Ki | 300.0 [1] |
| 3-(Hydroxymethyl)-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide | Ki | 1400000.0 [1] |
| 5-Fluoro-2-(4-pyridin-2-yl-piperazin-1-ylmethyl)-1H-indole | Ki | 400.0 [1] |
| 4-N-(4,5-Dihydro-1H-imidazol-2-yl)-1-N-[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine | Ki | 57.54 [1] |
| 7-Bromo-1,2,3,4-tetrahydro-3-(trifluoromethyl)-isoquinoline | Ki | 1000000.0 [1] |
| Amino({4-[(4-{[amino(iminio)methyl]amino}phenyl)amino]phenyl}amino)methaniminium | Ki | 1000.0 [1] |
| 3-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-1,5-dihydropyrimido[5,4-b]indole-2,4-dione | Ki | 1000.0 [1] |
| 7-Iodo-1,2,3,4-tetrahydroisoquinoline | Ki | 220.0 [1] |
| 1-[2-(3,4-Dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine | Ki | 181.0 [1] |
| 1H-Imidazole, 2-(2-fluoro-5-methylphenyl)-4,5-dihydro- | Ki | 10000.0 [1] |
| Guanidine, 4,4'-methylenediphenyldi- | Ki | 416.87 [1] |
| N-[4-[[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenyl]methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 1.58 [1] |
| N-(2-Chloro-4-iodophenyl)-2-methyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 2500.0 [1] |
| 7-Nitro-3-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline | Ki | 1400000.0 [1] |
| 3-Methyl-7-nitro-1,2,3,4-tetrahydroisoquinoline | Ki | 31000.0 [1] |
| 2-[4-[4-(Diaminomethylideneamino)benzoyl]phenyl]guanidine | Ki | 6309.57 [1] |
| 3-[2-(Azepan-1-yl)ethyl]-6-propyl-1,3-benzothiazol-2-one | Ki | 205.0 [1] |
| 2-Oxazolamine, 5-[(2-bromophenoxy)methyl]-4,5-dihydro- | Ki | 10000.0 [1] |
| Bis[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]methanone | Ki | 1584.89 [1] |
| N-((Hexahydro-1H-pyrrolizin-1-yl)methyl)-6-chloroimidazo(1,2-a)pyridine-8-carboxamide hydrochloride | IC50 | 10000.0 [1] |
| 6-Chloro-3-methyl-9-prop-2-enoxy-1,2,4,5-tetrahydro-3-benzazepine | Ki | 48.0 [1] |
| 3-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline | Ki | 400000.0 [1] |
| 2-(1,4-Benzodioxan-6-ylamino)-2-imidazoline | Ki | 3.1 [1] |
| 7-Methanesulfonyl-3-trifluoromethyl-1,2,3,4-tetrahydro-isoquinoline | Ki | 3900000.0 [1] |
| 3-Fluoro-4-[1-hydroxy-2-(methylamino)ethyl]pyrocatechol | Ki | 66.0 [1] |
| 2-(2,6-Dichloro-4-nitrophenylimino)imidazolidine | IC50 | 10000.0 [1] |
| 2-Hydroxymethyl Olanzapine | Ki | 783.0 [1] |
| Imidazolidine, 2-(2-methylphenylimino)- | Ki | 7.8 [1] |
| 3-[2-[4-(2-Chlorophenyl)-1-piperazinyl]ethyl]-1H-pyrimido[5,4-b]indole-2,4(3H,5H)-dione | Ki | 100000.0 [1] |
| 7-Isoquinolinecarbonitrile, 1,2,3,4-tetrahydro-3-(trifluoromethyl)- | Ki | 2900000.0 [1] |
| 4-[1-Hydroxy-2-(methylamino)ethyl]-5-fluoropyrocatechol | Ki | 9.0 [1] |
| (E)-N-[2-[2-(Dimethylamino)ethyl-methylamino]-4-methylquinolin-6-yl]-3-[4-(trifluoromethoxy)phenyl]prop-2-enamide | IC50 | 1.3 [1] |
| N-(Dicyclopropylmethyl)-2,3-dimethyl-3,4-dihydro-2H-pyrrol-5-amine | Ki | 10000.0 [1] |
| N-(2,6-Dichlorophenyl)-5-methyl-4,5-dihydro-1H-imidazol-2-amine | Ki | 1949.0 [1] |
| 2-Fluoro-3-[1-hydroxy-2-(methylamino)ethyl]phenol | Ki | 1200.0 [1] |
| Benzeneethanamine, 4-fluoro-beta,3-dihydroxy-N-methyl- | Ki | 1000.0 [1] |
| 1-[(Dimethylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 25.0 [1] |
| 1H-Indene-4,5-diol, 2,3-dihydro-1-[(methylamino)methyl]- | Ki | 7.0 [1] |
| 1H-Indene-4,5-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 15.0 [1] |
| 1-[(Dipropylamino)methyl]-2,3-dihydro-1H-indene-4,5-diol | Ki | 470.0 [1] |
| 1H-Indene-5,6-diol, 1-(aminomethyl)-2,3-dihydro- | Ki | 520.0 [1] |
| N-[4-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenoxy]phenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 100.0 [1] |
| N-[4-[4-(4,5-Dihydro-1H-imidazol-2-ylamino)phenyl]sulfanylphenyl]-4,5-dihydro-1H-imidazol-2-amine | Ki | 18.2 [1] |
| Benzeneethanamine, 2-fluoro-beta,5-dihydroxy-N-methyl- | Ki | 230.0 [1] |
| 2-[4-[4-(Diaminomethylideneamino)phenyl]sulfanylphenyl]guanidine | Ki | 269.15 [1] |
| 7-Bromo-3-methyl-1,2,3,4-tetrahydroisoquinoline | Ki | 1100.0 [1] |